The 2.125% convertible notes are due 2028

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Integer Holdings Corporation of $500 million aggregate principal amount of its 2.125% convertible senior notes due 2028, which included $65 million principal amount of notes pursuant to the exercise in full of the initial purchasers’ option to purchase additional notes. In addition, Davis Polk advised the counterparties to the capped call transactions entered into in connection with the offering.

Integer Holdings Corporation, headquartered in Plano, Texas, is among the world’s largest medical device outsource manufacturing companies, serving the cardiac, neuromodulation, orthopedics, vascular, advanced surgical and portable medical markets. Integer provides innovative, high quality medical technologies and also develops batteries for high-end niche applications in energy, military and environmental markets. Integer is listed on the New York Stock Exchange under the symbol “ITGR.”

The Davis Polk corporate team included partner Derek Dostal and associates Jakub P. Jozwiak and Kanger Jin. The equity derivatives team included partner Mark M. Mendez and associates Gregory Edgar Marchesini, Danielle Forni and Alexander S. Pettingell. Partner Lucy W. Farr and associate Tyler Scheiner provided tax advice. All members of the Davis Polk team are based in the New York office.